ANNEXIN A1 LIQUID PHARMACEUTICAL COMPOSITION

The present disclosure relates to a liquid pharmaceutical composition comprising an Annexin A1 (AnxA1) N-terminal-peptide and at least one pharmaceutically acceptable excipient for intravenous (i.v.) infusion and its use in the treatment of an ischemic condition and/or an inflammatory condition.5 La...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	JONASSEN, Thomas Engelbrecht Nordkild
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to a liquid pharmaceutical composition comprising an Annexin A1 (AnxA1) N-terminal-peptide and at least one pharmaceutically acceptable excipient for intravenous (i.v.) infusion and its use in the treatment of an ischemic condition and/or an inflammatory condition.5 La présente invention concerne une composition pharmaceutique liquide contenant un peptide N-terminal d'annexine A1 (AnxA1) et au moins un excipient pharmaceutiquement acceptable pour perfusion intraveineuse (IV) et son utilisation dans le traitement d'un état ischémique et/ou d'un état inflammatoire.